FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025480404> ?p ?o ?g. }

• W2025480404 endingPage "e17" @default.
• W2025480404 startingPage "e17" @default.
• W2025480404 abstract "In Ph-positive (Ph(+)) leukemia, the quiescent cell state is one of the reasons for resistance to the BCR-ABL-kinase inhibitor, imatinib. In order to examine the mechanisms of resistance due to quiescence and the effect of the mammalian target of rapamycin inhibitor, everolimus, for such a resistant population, we used Ph(+) acute lymphoblastic leukemia patient cells serially xenotransplanted into NOD/SCID/IL2rγ(null) (NOG) mice. Spleen cells from leukemic mice showed a higher percentage of slow-cycling G(0) cells in the CD34(+)CD38(-) population compared with the CD34(+)CD38(+) and CD34(-) populations. After ex vivo imatinib treatment, more residual cells were observed in the CD34(+)CD38(-) population than in the other populations. Although slow-cycling G(0) cells were insensitive to imatinib in spite of BCR-ABL and CrkL dephosphorylation, combination treatment with everolimus induced substantial cell death, including that of the CD34(+)CD38(-) population, with p70-S6 K dephosphorylation and decrease of MCL-1 expression. The leukemic non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mouse system with the in vivo combination treatment with imatinib and everolimus showed a decrease of tumor burden including CD34(+) cells. These results imply that treatment with everolimus can overcome resistance to imatinib in Ph(+) leukemia due to quiescence." @default.
• W2025480404 created "2016-06-24" @default.
• W2025480404 creator A5002642944 @default.
• W2025480404 creator A5008097340 @default.
• W2025480404 creator A5019005679 @default.
• W2025480404 creator A5027874681 @default.
• W2025480404 creator A5042332379 @default.
• W2025480404 creator A5057202650 @default.
• W2025480404 creator A5063329916 @default.
• W2025480404 creator A5069675532 @default.
• W2025480404 creator A5084655190 @default.
• W2025480404 creator A5086056792 @default.
• W2025480404 date "2011-05-13" @default.
• W2025480404 modified "2023-10-18" @default.
• W2025480404 title "The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells" @default.
• W2025480404 cites W120597284 @default.
• W2025480404 cites W1964270831 @default.
• W2025480404 cites W1965323879 @default.
• W2025480404 cites W1975317091 @default.
• W2025480404 cites W1983641075 @default.
• W2025480404 cites W1992000579 @default.
• W2025480404 cites W1992880652 @default.
• W2025480404 cites W2000590734 @default.
• W2025480404 cites W2005150241 @default.
• W2025480404 cites W2005317787 @default.
• W2025480404 cites W2007710816 @default.
• W2025480404 cites W2007772627 @default.
• W2025480404 cites W2009886857 @default.
• W2025480404 cites W2014345967 @default.
• W2025480404 cites W2024495487 @default.
• W2025480404 cites W2024841712 @default.
• W2025480404 cites W2058564254 @default.
• W2025480404 cites W2062646606 @default.
• W2025480404 cites W2062714572 @default.
• W2025480404 cites W2066796309 @default.
• W2025480404 cites W2071394735 @default.
• W2025480404 cites W2091742850 @default.
• W2025480404 cites W2099616647 @default.
• W2025480404 cites W2110648386 @default.
• W2025480404 cites W2115655607 @default.
• W2025480404 cites W2134138119 @default.
• W2025480404 cites W2134234801 @default.
• W2025480404 cites W2140254135 @default.
• W2025480404 cites W2145265436 @default.
• W2025480404 cites W2146317534 @default.
• W2025480404 cites W2147863207 @default.
• W2025480404 cites W2154856176 @default.
• W2025480404 cites W2158355674 @default.
• W2025480404 cites W2164857073 @default.
• W2025480404 cites W2169064989 @default.
• W2025480404 cites W2170975933 @default.
• W2025480404 cites W4238567307 @default.
• W2025480404 cites W560362396 @default.
• W2025480404 doi "https://doi.org/10.1038/bcj.2011.16" @default.
• W2025480404 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3255258" @default.
• W2025480404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22829152" @default.
• W2025480404 hasPublicationYear "2011" @default.
• W2025480404 type Work @default.
• W2025480404 sameAs 2025480404 @default.
• W2025480404 citedByCount "12" @default.
• W2025480404 countsByYear W20254804042014 @default.
• W2025480404 countsByYear W20254804042016 @default.
• W2025480404 countsByYear W20254804042018 @default.
• W2025480404 countsByYear W20254804042019 @default.
• W2025480404 countsByYear W20254804042022 @default.
• W2025480404 crossrefType "journal-article" @default.
• W2025480404 hasAuthorship W2025480404A5002642944 @default.
• W2025480404 hasAuthorship W2025480404A5008097340 @default.
• W2025480404 hasAuthorship W2025480404A5019005679 @default.
• W2025480404 hasAuthorship W2025480404A5027874681 @default.
• W2025480404 hasAuthorship W2025480404A5042332379 @default.
• W2025480404 hasAuthorship W2025480404A5057202650 @default.
• W2025480404 hasAuthorship W2025480404A5063329916 @default.
• W2025480404 hasAuthorship W2025480404A5069675532 @default.
• W2025480404 hasAuthorship W2025480404A5084655190 @default.
• W2025480404 hasAuthorship W2025480404A5086056792 @default.
• W2025480404 hasBestOaLocation W20254804041 @default.
• W2025480404 hasConcept C10205521 @default.
• W2025480404 hasConcept C126322002 @default.
• W2025480404 hasConcept C159912055 @default.
• W2025480404 hasConcept C203014093 @default.
• W2025480404 hasConcept C2777583451 @default.
• W2025480404 hasConcept C2778461978 @default.
• W2025480404 hasConcept C2778729363 @default.
• W2025480404 hasConcept C2779699572 @default.
• W2025480404 hasConcept C28328180 @default.
• W2025480404 hasConcept C2908647359 @default.
• W2025480404 hasConcept C3019892230 @default.
• W2025480404 hasConcept C502942594 @default.
• W2025480404 hasConcept C71924100 @default.
• W2025480404 hasConcept C86803240 @default.
• W2025480404 hasConcept C95444343 @default.
• W2025480404 hasConcept C99454951 @default.
• W2025480404 hasConceptScore W2025480404C10205521 @default.
• W2025480404 hasConceptScore W2025480404C126322002 @default.
• W2025480404 hasConceptScore W2025480404C159912055 @default.
• W2025480404 hasConceptScore W2025480404C203014093 @default.
• W2025480404 hasConceptScore W2025480404C2777583451 @default.

• next